Filter your results
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
JAK inhibition for CD3− CD4+ lymphocytic-variant hypereosinophilic syndromeClinical Immunology, 2023, pp.109275. ⟨10.1016/j.clim.2023.109275⟩
Journal articles
hal-04019811v1
|